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including TNF–α. Side effects were limited to bone pain and elevation of alkaline phos-
phatase. One of 6 patients developed worsening of heart failure; however this was rapidly
reversible. Long term studies are required to evaluate the effect on cardiac remodeling
and function.
1108-131 Kinetics of Circulating Endothelial Progenitor Cells in 
Congestive Heart Failure
Mutsuko Sarukawa, Keiji Yamamoto, Noriko Ueda, Yoshioki Nishimura, Masaru Ichida, 
Kazuo Muroi, Kazuyuki Shimada, Jichi Medical School, Tochigi, Japan
Background: Endothelial progenitor cells (EPCs) circulate in the adult peripheral blood
(PB) and contribute to neovascularization. EPCs are considered to be included in CD34
positive mononuclear cells (CD34+ MNCs). Kinetics of circulating EPCs in congestive
heart failure (CHF) has not been fully investigated. 
Methods: We determined the numbers of WBC and CD34+ MNCs, plasma BNP, serum
erythropoietin, VEGF and thrombomodulin levels in 16 mild CHF patients (NYHA I or II),
10 severe CHF patients with acute exacerbation (NYHA III or IV), and 22 control sub-
jects. In severe CHF patients, blood sampling was performed at admission and on 14
days after admission. The number of CD34+ MNCs in PB was quantified by flowcytome-
try.
Results: The ratio of CD34+ MNCs: WBC (x1000) in mild CHF patients (0.462±0.107)
was higher than that in control subjects (0.267±0.018, p<0.05). Interestingly, the ratio of
CD34+ MNCs: WBC in severe CHF patients at admission (0.155±0.035) was significantly
lower than that in control subjects (p<0.005) or in mild CHF patients (p<0.05). Levels of
BNP (1183±505 pg/ml) and erythropoietin (117±52 mU/ml) in severe CHF patients were
significantly higher than those (BNP, 306±117, p<0.05; erythropoietin, 27±5, p<0.05) in
mild CHF patients. However, VEGF and thrombomodulin levels were not different
between mild and severe CHF patients. In addition, the ratio of CD34+ MNCs: WBC in
severe CHF patients increased in proportion to the amelioration of CHF during hospital-
ization, and this increase correlated with the decrease in BNP levels.
Conclusion: The ratio of CD34+ MNCs: WBC was decreased in severe CHF. These find-
ings suggest that impaired EPC recruitment might be involved in the pathophysiology of
severe CHF.
1108-132 Percutaneous Intracoronary Transplantation of 
Autologous Stem Cells After Acute Myocardial 
Infarction
Clemens Steinwender, Robert Hofmann, Klaus Kerschner, Michael Grund, Kurt 
Sihorsch, Alexander Kypta, Jürgen Kammler, Wilma Maschek, Christian Gabriel, Franz 
Leisch, Cardiovascular Division City-Hospital Linz, Linz, Austria, Blutzentrale Linz, Linz, 
Austria
Background: Recent publications have shown, that transplantation of autologous stem
cells (ASC) after myocardial infarction (MI) improves cardiac function, but ASC were
always won by bone marrow aspiration.
We derived ASC by apheresis from peripheral blood and transplanted them via the inf-
arct-related coronary artery (IRCA).
Methods: Patients (P) with acute MI and primary intervention of the IRCA were included.
Two days after MI we initiated stimulation of the bone marrow with granulocyte-colony
stimulating factor (G-CSF, Neupogen®). Having achieved a peak of CD34-positive cells in
peripheral blood, apheresis and transplantation of ASC were performed. The ASC were
injected via the lumen of a balloon catheter, which was inflated within the stent of the
former coronary intervention of the IRCA.
After 6 months, stress-echocardiography, 18-FDG-positrone emission tomography (PET),
coronary angiography and ventriculography were performed.
Results: We included 10 P with a mean age of 57 + 12 years (9 males). The IRCA were
the left anterior descending coronary artery (n=3), the circumflex coronary artery (n=1),
the right coronary artery (n=5) and a venous bypass graft to the right coronary artery
(n=1), the mean left ventricular ejection fraction was 44,9 + 6%.
The mean dose of G-CSF was 63 + 25 Million IU per day, administered subcutaneousely.
Apheresis took place 5,5 + 1,2 days after starting G-CSF-therapy. Transplantation was
successfully performed in 9 P, 1 P revealed an asymptomatic reocclusion of the IRCA.
The injected suspension (9 millilitres per P) contained 3 to 4x106 CD34-positive cells per
millilitre.
After 6 months, all 9 P were alive. No new ischemic or arrhythmogenic events have
occured. Echocardiographic markers, PET and the mean ejection fraction (45,2 + 1%
after 6 months) did not change significantly. Coronary angiography revealed 1 instent-
restenosis, but no new stenoses or occlusions in the IRCA.
Conclusion: Sufficient extraction of ASC out of peripheral blood after bone marrow stimu-
lation with G-CSF and their transcoronary application via a balloon catheter is feasible
and safe. Randomized studies are neccessary to determine the clinical benefit of this
procedure.
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1109-103 Clinical Characteristics and Prevalence of Pericardial 
Effusion Using Cardiac Magnetic Resonance Imaging
Christopher K. Dyke, Peter Kellman, W. Patricia Ingkanisorn, Kenneth L. Rhoads, 
Anthony H. Aletras, Andrew E. Arai, National Heart, Lung, and Blood Institute, Bethesda, 
MD
Background: Pericardial effusion is a common finding during routine cardiac imaging.
Free living and referral population prevalence data are limited to echo-detected effusion,
but estimates using MRI have not been previously reported. The aim of the present study
is to report the prevalence of pericardial effusion detected in a population referred for car-
diac MRI and to determine significant associated clinical characteristics with MRI-
detected pericardial effusion. Methods: 832 consecutive patients who completed a car-
diac MRI examination at a tertiary center (n=188) or a community hospital (n=644) were
evaluated. Effusion was identified using cine Steady State Free Precession, double inver-
sion recovery-fast spin echo, or inversion recovery. Echocardiographic size criteria were
used to categorize the effusion as small, moderate, or large. Logistic regression was per-
formed to assess the relationship between potential risk factors and the presence of peri-
cardial effusion. Results: MRI-detected prevalence of pericardial effusion was 15%
(n=125) and was similar in the referral populations. Of the effusions, 75% (n=93) were
small, 18% (n=23) were moderate, and 7% (n=9) were large. In the multivariate model,
cancer (p<0.001), LVEF<45% (p<0.001), women (p=0.001), and hypertension (p=0.002)
were significant predictors of effusion. The odds ratio was highest in cancer (3.9),
LVEF>45% (2.9), women (2.3), and hypertension (2.1) (all p<0.002). Prevalence did not
vary with age (p=0.56). Patients with prior bypass surgery had a lower prevalence of effu-
sion (p<0.001, OR 0.12). Conclusions: The findings from this study represent the first
prevalence estimates of pericardial effusion in a large consecutive series of patients
referred for cardiac MRI. Prevalence of MRI-detected pericardial effusion is 15% and was
more common in women, a finding that compels further investigation. Effusion was also
more common in patients with cancer, hypertension, or ventricular dysfunction. Contrary
to prior reports, no association with age was seen, possibly due to the ability of MRI to
more accurately determine fat from fluid in the pericardial space.
1109-104 Angiographic Features That Assist in Making the 
Distinction Between Constrictive Pericarditis and 
Restrictive Cardiomyopathy
Deepak R. Talreja, Stuart T. Higano, Rick A. Nishimura, Jae K. Oh, David R. Holmes, 
Mayo Clinic, Rochester, MN
Background: Constrictive pericarditis (CP) may be difficult to distinguish from other
causes of congestive heart failure (CHF) especially restrictive cardiomyopathy
(RCM).While hemodynamic evidence of enhanced ventricular interaction with respiration
can be detected with high-fidelity pressure measurement, these techniques may be sup-
plemented by other methods. Since these patients frequently undergo coronary angiog-
raphy we examined angiographic films for findings that may distinguish CP from other
CHF.
Methods: We retrospectively reviewed the coronary angiograms in eleven consectutive
patients with surgically-proven CP, excluding all cases with prior cardiothoracic surgery.
These angiograms as well as another 7 from patients with other causes of CHF in the
absence of prior cardiothoracic surgery were blindly reviewed and scored regarding the
presence of pericardial calcification (thickness and density, grades 0-3) and fixation of
the epicardial coronary arteries (grades 0-3).
Results: While there was no significant difference in the incidence of coronary calcifica-
tion or mitral annular calcification between the groups, pericardial calcification was seen
in was seen in 5 of 11 patients with CP and none with other causes of CHF. Significant
fixation of the distal coronary arteries (characterized by a greater than 50% change in
vessel angulation with systole) was seen in 7 patients with CP and none with other CHF
(p < 0.012), while mild fixation occurred in both groups. Abnormal motion of the septal
perforators was seen more frequently in the CP group, but not significantly (45% vs 29%,
p = ns).
Conclusion: The finding of pericardial calcification on angiography in patients with symp-
toms of congestive heart failure is strongly suggestive of underlying pericardial constric-
tion. Fixation of the distal coronary arteries may support this diagnosis. In addition to the
hemodynamic profile showing ventricular interaction, these findings may help support a
diagnosis of constrictive pericarditis.
1109-105 Survival Predictor Analysis for Patients With 
Tuberculosis Pericarditis: A 15-Year Prospective Follow-
Up Study
Ping-Yen Liu, Jyh-Hong Chen, Li-Jen Lin, Yu-Jen Yung, Liang-Miin Tsai, National Cheng-
Kung University, Taiwan, Taiwan,ROC
Background: Tuberculosis is one of the most important causes in chronic pericarditis,
especially in Taiwan. Echocardiographic intrapericardial abnormalities are helpful in the
diagnosis of tuberculous pericarditis. However, the survival prognostic values of the
echocardiographic findings or clinical symptoms are not well defined yet. Furthermore,
the effects of anti-mycobacterial (anti-TB) treatment duration and additional combination
of corticosteroids on mortality of tuberculous pericarditis are poorly understood.
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Methods: Sixty-four consecutive patients (mean age 63.5 ± 14.8 years; 65.6% male)
diagnosed to have tuberculous pericarditis were included. All patients underwent surgical
treatment. Detailed echocardiographic examinations were performed before operation.
Their clinical manifestations were analyzed from the medical recordings.
Results: After a median follow-up period of 5.37 ± 3.68 years (range 1 month to 15
years), there were 24 (37.5%) deaths among this cohort. We found that thickened peri-
cardium observed by the echocardiography (95.8 vs. 45.0%, odds ratio [OR] 2.18, p
<0.001) and initial symptoms of congestive heart failure (CHF) (79.2 vs. 40.0%, OR 1.81,
p = 0.004) were more common among patients complicated with mortality. In addition,
less frequent treatment with corticosteroids and shorter duration of anti-TB treatment
were found among mortality patient group (20.8 vs. 65.0%, OR 0.51, p <0.001; 2.16 ±
3.85 vs. 7.11 ± 4.14 months, p <0.001). Multivariate Cox regression analysis showed that
thickened pericardium was an independent and significant predictor of death (hazard
ratio 2.38, p = 0.02) as were CHF symptoms (hazard ratio 2.39, p = 0.02), usage of corti-
costeroids (hazard ratio 0.45, p=0.04) and an anti-TB treatment duration longer than 6
months (hazard ratio 0.33, p = 0.001).
Conclusion: We conclude that the echocardiographic finding of thickened pericardium
and symptoms of CHF can be survival predictors for tuberculous pericarditis. Combina-
tion usage of corticosteroids and anti-TB treatment longer than 6 months may improve
the outcome of tuberculous pericarditis.
1109-106 Mitral and Tricuspid Inflow Velocities and Their Variation 
With Respiration Are Better Predictors of Cardiac 
Tamponade Than Right Atrial and Ventricular Collapse: 
A Combined Echocardiographic and Hemodynamic 
Study
John G. Morgan, Malissa J. Wood, Arthur E. Weyman, Massachusetts General Hospital, 
Boston, MA
Background: Echocardiography has become crucial in the diagnosis of cardiac tampon-
ade. Criteria assessing cardiac chamber inversion and respirophasic changes in mitral
inflow (MI) and tricuspid inflow (TI) velocities have been used to diagnose cardiac tam-
ponade, however there is often a discrepancy between the groups of signs. Previous
studies have used various criteria for tamponade with a limited number of patients having
invasive hemodynamics. We sought to determine which echocardiographic parameters
best predict the hemodynamic changes of tamponade.
Methods: 60 patients who underwent trans-thoracic echo and subsequent pericardio-
centesis (PC) with right heart catheterization were studied. Evidence of prolonged right
atrial, right ventricular or left atrial (LA) inversion were assessed. Peak MI and TI veloci-
ties and their respiratory variation were examined. Right heart and pericardial pressures
and the cardiac index (CI) pre and post PC were recorded.
Results: Respiratory variation in MI and TI was weakly but significantly correlated with
pericardial pressure pre PC (MI and TI variation vs pericardial pressure: r= .32, p=.02
and r=.29,p=.04). MI variation was also correlated with CI pre PC (r= .45, p=.009). The
MI and TI velocities were also predictive and better correlated with the CI pre PC. (MI and
TI vs CI: r= .63, p<.001 and r=.63, p<.001 respectively ). MI velocity predicted pericardial
pressure(r=.34, p=.02), TI velocity did not. An inspiratory MI velocity >80 cm/s or TI
velocity >70cm/s excluded a CI < 2.5litres/min. In contrast, there was no difference in
pericardial pressure or CI pre PC in the group who had right atrial or ventricular inversion
vs those who did not. Patients with LA inversion had a higher pericardial pressure
(18.8±3.5 vs 13.2±2.3, p=0.008) and lower CI (2.10±0.6 vs2.97±0.3, p=0.02) than those
without.
Conclusions: In pericardial effusions, respiratory variation in MI and TI is weakly predic-
tive of pericardial pressure while MI variation predicts CI. MI and TI velocities are corre-
lated with CI. LA inversion predicts lower CI and higher pericardial pressure however
right atrial and ventricular collapse are not predictive of the degreeof these hemodynamic
changes.
1109-107 Minimally Invasive Transdiaphragmatic Pericardial 
Shunting Assisted by Video Thoracoscope and 
Transesophageal Echocardiography
Tamas Habon, Laszlo Czopf, Elod Papp, Ferenc Sari, Kalman Toth, Tamas F. Molnar, 
University of Pecs, Medical School, Pecs, Hungary
Background: The first description of pericardio-peritoneal shunt with laparoscopic
approach originates from the early nineties. Technical details were developed. The effi-
cacy, and safety of this approach was tested.
Methods: Continuous transesophageal echocardiographic (TEE) control, supraumbili-
cally introduced camera secured direct vision for trocars in the left and right hypochon-
drium of the patients in a modified lithotomy position was used. Grasping the diaphragm
anterolaterally to the hiatus esophagei, the diaphragm-pericardium complex was cut
through using a harmonic scalpel, creating a hole of 3-5 cm. Ten patients (mean age:
55.8 years, 7 male, 3 female) with significant amount of recurrent pericardial effusion
were operated on using this technique. Eight of them suffered from malignant disease (6
lung, 1 colon, 1 breast cancer), uremia and pemphigus were the underlying diseases in
the remaining two cases.
Results: Eight out of the ten procedures lasted less than 20 minutes. Tamponade was
relieved in all cases immediately. All the windows have remained patent until death of the
patients (3 cases with malignant disease) or are open currently (7 cases, 3-15 months
follow-up). All but one patient were discharged on the day after the procedure.
Conclusion: Under transesophageal echocardiographic (2D and Doppler) control the pro-
cedure is safe, no drains are left behind. Elevated intrapericardial pressure pumps the
fluid out and prevents spontaneous closure of the hole. The usage of ultracision mini-
mizes the risk of epicardial injury, clips are not necessary. This technique seems to be
ideal both as a palliation and as a sulution in non malignant cases, without adverse reac-
tions.
1109-108 Diagnostic Tests Have Incremental Value in Predicting 
Clinical Outcomes in Constrictive Pericarditis
Lieng H. Ling, Jae K. Oh, Smonporn Boonyaratavej, Christopher P. Appleton, Jerome F. 
Breen, Marion E. Barnes, Ana G. Rosales, Rick A. Nishimura, Hartzell V. Schaff, A. Jamil 
Tajik, Mayo Clinic, Rochester, MN
Background: Echocardiography (Echo), computed tomography (CT) and cardiac cathe-
terization (Cath) have proven value in diagnosing constrictive pericarditis (CP). The prog-
nostic implications of test findings are however less evident.
Methods: Echo, CT and Cath studies of 211 patients with CP (57±15 yrs) who had peri-
cardiectomy at Mayo Clinic were analyzed. Clinical predictors of postoperative (postop)
death, late cardiovascular (CV) death, and recurrent CHF were identified, and Echo, CT
and Cath variables entered stepwise into clinical models to assess incremental prognos-
tic value. Echo variables included LV dimensions and ejection fraction, LA and RA vol-
umes, mitral E/A ratio and deceleration time and inferior vena caval size. CT variables
were calcified pericardium and maximum pericardial thickness. Cath variables included
mean RA, RV and LV end-diastolic, pulmonary artery systolic and pulmonary capillary
wedge pressures.
Results: Echo was performed in 197 pts (93%), CT in 142 (67%) and Cath in 112 (53%).
There were 26 postop deaths, 21 late CV deaths and 59 CHF events over a median fol-
low-up of 61 months. Clinical and test predictors of these outcomes are tabulated. 
HR=hazard ratio, CI=confidence intervals
Conclusions: Calcified pericardium, pulmonary hypertension and markedly elevated fill-
ing pressures are independently associated with adverse outcomes in CP. Their detec-
tion by current diagnostic modalities yields prognostic information incremental to clinical 
variables.
1109-133 The Role of Pericardioscopy and Epicardial Biopsy in 
Determination of the Etiological Treatment for Chronic 
Pericardial Effusions
Bernhard Maisch, Arsen D. Ristic, Sabine Pankuweit, Andreas Neubauer, Roland Moll, 
Klaus Havemann, Philipps-University, Marburg, Germany
Background: Assessment of the etiology of pericardial disease has important therapeutic
implications. The aim of this study was to evaluate the clinical efficacy and safety of etiol-
ogy-specific intrapericardial treatment with cisplatin or triamcinolone.
Methods: Out of the registry of 260 pts undergoing pericardiocentesis, 42 pts with cyto-
logically verified neoplastic pericardial effusion (PE) (Group 1) were selected for cisplatin
treatment (single dosis of 30 mg/m2/24h). Further 84 pts with autoreactive chronic PE
were treated intrapericardially with two different triamcinolone regimens (Group 2), triam-
cinolone 600 mg/m2/24h; Group 3, triamcinolone 300 mg/m2/24h). PE and pericardial/
epicardial biopsy analyses included biochemistry, cytology, serology, microbiology, histol-
ogy, immunohistology, and PCRs for microbial DNA/RNA.
Results: The following malignancies were established: lung cancer - 52.4%, breast can-
cer - 19.0%, Morbus Hodgkin - 4.8%, esophageal cancer - 2.4%, mesothelioma - 2.4%,
colon cancer - 4.8%, and undifferentiated cancer of unknown origin - 14.3%. None of the
pts intrapericardially treated with cisplatin died due to cardiac tamponade. Mortality due
to non-cardiac tumor progression was 52.4% and 80.9%, after 3 and 6 months respec-
tively. Cisplatin prevented recurrence of symptoms and a hemodynamically relevant PE
during the first 3 months of the follow-up in 92.8% of the pts, and after 6-12 months in
83.3% of the pts. Triamcinolone treatment resulted in symptomatic improvement and pre-
vented PE recurrence in 92.6% vs. 86.7% of the pts after 3 months and in 85.1% vs.
83.3% after 1 year in the Group 2 and Group 3 respectively (p>0.05). During the follow-
up 29.6% of the pts developed transitory iatrogenic Cushing syndrome in the Group 1 vs.
13.3% in the Group 2 (p<0.05).
Conclusion: Intrapericardial treatment of neoplastic pericarditis with cisplatin significantly
prevented recurrences of symptoms and PE during the follow-up of 12 months. Intraperi-
cardial treatment of autoreactive chronic/recurrent PE with 300 mg/m2/24h of triamcino-
lone prevented recurrences of symptoms and relapses of PE equally effective as the 600
mg/m2/24h regimen.
Event Predictor HR 95% CI P
Postop death Mediastinal irradiation
Cath: Pulmonary capillary wedge pressure
CT: Calcified pericardium
Age at surgery
4.50
1.92
1.53
1.04
1.65-12.31
1.07-3.42
1.01-2.30
1.00-1.08
0.003
0.028
0.043
0.034
Late CV death Mediastinal irradiation
History of coronary disease
Atrial fibrillation
NYHA class
Echo: Mitral E wave deceleration time
6.37
4.30
3.87
3.53
1.85
2.48-16.38
1.71-10.81
1.51-9.92
1.41-8.89
1.12-3.04
<0.001
0.002
0.005
0.007
0.019
CHF Mediastinal irradiation
Atrial fibrillation
Cath: Pulmonary artery systolic pressure
CT: Calcified pericardium
Age at surgery
4.07
2.13
1.71
1.40
1.03
2.04-8.12
1.21-3.75
1.24-2.36
1.12-1.76
1.01-1.05
<0.001
0.009
0.001
0.004
0.002
